Add time:09/09/2019         Source:sciencedirect.com

1,1,3,3,6-Pentamethyl-1,3-disilaindan-5-ol (2) is a key intermediate in the synthesis of new sila-substituted gonadotropin releasing hormone receptor antagonists, such as 1. In order to produce sufficient quantities of 1 for pharmacological and toxicological evaluation, an efficient synthesis of 2 has been developed. (1,1,3,3,6-Pentamethyl-1,3-disilaindan-5-yl)methanal (11) was synthesized in a one-pot procedure. CoBr2/Zn-catalyzed [2+2+2] cycloaddition of diyne 3 with the commercially available monoalkyne 15 was achieved through a slow addition of 3 and CoBr2 to a mixture of 15 and zinc powder in refluxing acetonitrile, giving rise to 5-(diethoxymethyl)-1,1,3,3,6-pentamethyl-1,3-disilaindane (14). In-situ aqueous acidification yielded 11. Conversion to 2 was then achieved via a Baeyer–Villiger oxidation followed by hydrolysis under basic condition. This novel methodology is useful, not only for the rapid, large-scale synthesis of 2, but also for the synthesis and development of new sila-substituted drugs derived from 11.

We also recommend Trading Suppliers and Manufacturers of 2-(Diethoxymethyl)-1H-imidazole (cas 13750-84-0). Pls Click Website Link as below: cas 13750-84-0 suppliers